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ABSTRACT  
Background: FOXP3+ regulatory T cells (Tregs) restraint the destructive potential of 
the immune system. We have previously reported a pronounced reduction of circulating 
Tregs in infants with severe respiratory syncytial virus (RSV) disease. Because IL-2 is 
critical for Treg growth, survival and activity, we here analyzed IL-2 production and 
function in RSV-infected infants.   
Methods: Phenotype, proliferation, IL-2 production and IL-2 signaling in CD4+ T cells 
were analyzed by flow cytometry. Serum CD25 levels were quantified by ELISA.   
Results: CD4+ T cells from RSV-infected infants produced lower amounts of IL-2 and 
showed a reduced proliferative response compared with healthy infants. IL-2 increased 
CD4+ T cell proliferation and FOXP3 expression in both, healthy and RSV-infected 
infants. However, despite IL-2 induced a similar pattern of STAT5 phosphorylation, the 
proliferative response of CD4+ T cells and the expression of FOXP3+ remained 
significantly lower in RSV-infected infants. Interestingly, we found a negative 
correlation between disease severity and both, the production of IL-2 by CD4+ T cells 
and the ability of exogenous IL-2 to restore the pool of FOXP3+CD4+ T cells.  
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Conclusions: A reduced ability to produce IL-2 and a limited response to this cytokine 
might affect the function of CD4+ T cells in RSV-infected infants.  
 
Key words: Respiratory syncytial virus, infants, severe bronchiolitis, CD4+ T cells, 
FOXP3, IL-2, sCD25, CD25.   
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INTRODUCTION 
Respiratory syncytial virus (RSV) infection is the commonest cause of bronchiolitis and 
hospitalization in infants accounting for about 100 000–200 000 deaths annually [1]. 
Pathogenesis of RSV infection involves both, cytopathic effects induced by the virus 
and an exacerbated inflammatory response which explain, at least partially, the airway 
damage [2, 3]. FOXP3+ regulatory T cells (Tregs) not only prevent autoimmune 
diseases and maintain immune homeostasis, but also regulate the immune response in 
the course of infectious diseases controlling tissue injury [4, 5]. In fact, experimental 
models of RSV infection have shown that depletion of Tregs leads to a more severe 
disease [6-8]. The role of Tregs during human RSV infection has not been clarified yet. 
However, the Treg cell compartment undergoes important changes in the course of 
severe RSV infection. In this regard, we have previously reported that severe RSV 
infection in infants is associated with a marked reduction in the frequency of peripheral 
blood Tregs [9].  
 
Most studies analyzing the role of Tregs have focused on chronic conditions, such as 
autoimmunity, cancer, and persistent infectious diseases [10-13]. By contrast, very little 
is known about the function of Tregs in acute viral infections. Our previous findings 
showing the depletion of Tregs in RSV infected infants contrast with the increased 
frequencies of Tregs found in other acute viral diseases such as dengue [14] and 
influenza A virus (IAV) [15], suggesting a particular signature of RSV infection. 
Because Treg survival and function are dependent on IL-2 receptor signaling [16], we 
speculated that severe RSV disease could be associated with a dysregulation of the IL-
2/IL-2R system. This hypothesis might also explain another key feature of RSV 
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infection, its inability to induce long-lasting immunity, a response strongly dependent 
on IL-2 function [17].   
 
Here, we found that the production and function of IL-2 are compromised in infants 
with severe RSV infection. CD4+ T cells from RSV infected patients produced lower 
amounts of IL-2 and showed a limited proliferative response compared with cells 
from healthy donors. We also found that the addition of IL-2 failed to fully restore 
IL-2-dependent functions such as FOXP3 expression and CD4+ T cell proliferation. 
Interestingly, a negative correlation was observed between disease severity and both, 
IL-2 production by CD4+ T cells and IL-2 ability to increase the pool of 
FOXP3+CD4+ T cells.  
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MATERIALS AND METHODS 
Ethics Statement 
Our study was approved by the Ethics Committee of the “Hospital de Pediatría Pedro de 
Elizalde”, Buenos Aires, Argentina, in accordance with the Declaration of Helsinki 
(Fortaleza 2013). Written informed consent was obtained from all donors or legal 
guardians. 
 
Study population  
We recruited 85 infants < 18 months old hospitalized at the “Hospital de Pediatría Pedro 
de Elizalde” (Buenos Aires, Argentina), with a severe episode of RSV bronchiolitis 
during the 2016-2017 respiratory seasons. We excluded children with history of 
prematurity, immunodeficiency, congenital heart disease, and chronic conditions. All of 
these infants required hospitalization. RSV infection was confirmed by direct 
immunofluorescence of nasopharyngeal aspirates. Disease severity was assessed by 
applying a clinical disease severity score (CDSS) based on the modified Tal score, 
which classified patients as having mild (0–4), moderate (5–8), or severe (9–12) RSV 
bronchiolitis at the time of sampling [18, 19]. Control group consisted in 40 infants 
admitted to the hospital for scheduled surgery (healthy donors, HD). They had no 
identifiable airway infections for a 4-week period before the study. Characteristics of 
the patients are shown in Table 1.  
 
Isolation of peripheral blood mononuclear cells  
Peripheral blood mononuclear cells (PBMCs) were obtained from blood samples (0.3 to 
0.4 ml) from RSV-infected infants or HD, by Ficoll-Hypaque gradient centrifugation 
(GE Healthcare Life Sciences, Uppsala, Sweden). PBMCs were washed twice, and 
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suspended in complete culture medium: RPMI 1640 (Hyclone, Logan, Utah, USA) 
supplemented with 10% heat-inactivated fetal calf serum (FCS, Natocor, Córdoba, 
Argentina), 200 mM L-glutamine and 50 g/ml gentamicin (Sigma-Aldrich, St. Louis, 
MO, USA).  
 
Flow cytometry  
Labeled mAb directed to CD3, CD4, CD8, CD14, CD19, CD25, CD39, FOXP3, IL-2, 
STAT5, and Ki-67 were all from BD Biosciences (San José, CA, USA). In all cases, 
isotype-matched mAb were used as controls. For intracellular IL-2 detection, cells were 
stimulated with 50 ng/ml PMA and 1 µg/ml ionomycin (Sigma-Aldrich) for 5 h in the 
presence of monensin (Golgi-Stop, BD Biosciences), and stained with anti-CD4 and 
anti-IL-2 mAbs, after cell fixation and permeabilization (BD Biosciences). To analyze 
STAT5 phosphorylation in CD4+ T cells, PBMCs were treated, or not, with IL-2 (20 
ng/ml, Peprotech, Rocky Hill, NJ, USA) for 30 min at 37ºC. Cells were then stained 
with a mAb directed to phosphorylated STAT5, after cell fixation and permeabilization. 
Data were acquired using a FACS Canto (Becton Dickinson) and analyzed with FlowJo 
software. Statistical analyses were based on at least 100,000 events gated on the 
population of interest. 
 
Culture of PBMCs in the presence of IL-2  
To test the proliferative response of CD4+ T cells, PBMCs from RSV or HD (1x10
6 
cells/ml) were activated with PHA (4 µg/ml, Sigma-Aldrich) and cultured in the 
absence or presence of IL-2 (20 ng/ml) during 3 d. Then, the expression of the 
proliferation marker Ki-67 was assessed by flow cytometry. The concentration of IL-2 
used in these assays was selected on the basis of preliminary experiments performed 
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with PBMCs from healthy children. These experiments showed that the proliferation of 
PHA-activated CD4+ T cells reached similar values by using either 20 or 100 ng/ml of 
IL-2. To test the ability of IL-2 to increase the expression of FOXP3, resting PBMCs 
(1x10
6 
cells/ml) were cultured without or with IL-2 (20 ng/ml) for 24 h. In some 
experiments, resting PBMCs were cultured with IL-2 alone or IL-2 plus recombinant 
soluble CD25 (sCD25, 200 ng/ml, Peprotech), for 30 min or 24 h, and phosphorylation 
of STAT5 and FOXP3 expression was evaluated.  
 
Culture of PBMCs in the presence of serum from RSV-infected or healthy children 
Serum was obtained from HD and RSV-infected children, while PBMCs were obtained 
from unrelated healthy adult donors. Briefly, PBMCs (1x10
6
/ml) were incubated for 24 
h in complete culture medium supplemented with heat-inactivated serum from healthy 
or RSV-infected children (final dilution 1:10), in the absence or presence of IL-2 (20 
ng/ml). Then, the frequency of FOXP3+CD4+ T cells was analyzed. Flow cytometry 
crossmatch was used to detect the presence or lack of IgG antibodies on the surface of 
CD4+ lymphocytes, after incubation of PBMCs with serum samples. In no case, we 
detected the presence of cell-associated IgG antibodies. 
 
Cytometric Bead Array (CBA)  
PHA (4 µg/ml)-activated PBMCs (1x 10
6
/ml) were cultured during 3 d and the 
supernatants obtained were frozen until use. Measurement of IL-2, IL-4, IL-6, IL-10, 
IL-17, TNF-α and IFN-γ was assessed according to the manufacturer's protocol (BD 
Biosciences). Data were acquired using a FACS Canto.     
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ELISA 
Serum levels of sCD25 were determined by ELISA (Thermo Fisher, Fredrick, MD, 
USA). 
 
Statistical analysis 
Statistical analyses were performed using GraphPad Prism software. Data normality 
was evaluated by Shapiro Wilk test. Groups were compared using the Chi-Square test or 
Wilcoxon signed rank test and/or Mann-Whitney test as appropriate. Correlations were 
assessed using Spearman correlation test. A p value <0.05 was considered statistically 
significant.  
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RESULTS 
Clinical characteristics of study population  
The characteristics of RSV-infected and healthy infants enrolled in this study are 
summarized in Table 1. The CDSS of all admitted patients was equal or higher than 
seven. All admitted patients needed O2 requirement. Those admitted to intensive care 
unit (n=3, 3.6%) required invasive mechanical ventilation for a median of 4.5 d  (range, 
3.6–5.9 d) and received broad-spectrum antibiotic therapy. RSV-infected children 
showed a higher frequency of B cells (CD19+ cells) and a lower frequency of CD8+ T 
cells compared with HD. The frequency of CD4+ T cells was similar in both groups.  
 
CD4+ T cells from RSV- infected infants produce low amounts of IL-2 and show a 
decreased proliferative response  
We first analyzed whether the production of IL-2, which is mainly mediated by 
conventional CD4+ T cells [20], might be reduced during severe RSV infection. 
PBMCs from RSV-infected and HD were stimulated for 5 h with PMA/ionomycin in 
the presence of monensin, and IL-2 production was analyzed by intracellular staining 
and flow cytometry in gated CD4+ T cells. We observed a similar frequency of IL-
2+CD4+ T cells in RSV-infected and HD, however, the mean fluorescence intensity 
(MFI) of IL-2 staining was significantly lower in infected patients (Fig. 1A). 
Interestingly, an inverse correlation was found between disease severity (CDSS) and the 
MFI of IL-2 staining in activated CD4+ T cells from RSV-infected patients. Moreover, 
because young age represents one of the most important risk factors for the 
development of severe RSV disease [1], we re-analyzed our data by dividing patients 
into two groups; <6 months and >7 months. Both groups of patients showed a lower 
production of IL-2 compared with HD (Fig. 1A, right panel). To confirm that CD4+ T 
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cells from RSV-infected children actually produced low amounts of IL-2, we analyzed 
IL-2 production in the supernatants of PBMCs stimulated with PHA for 3 d, using a 
cytometric bead array (CBA).  IL-2 levels were markedly lower in RSV-infected 
children compared with HD. Moreover, we found that cells from RSV-infected children 
produced lower amounts of IL-10 and IL-17. No significant differences were observed 
regarding the production of IL-4, IL-6, TNF-α, and IFN- (Fig. 1B)  
 
Consistent with our observations indicating a deficient production of IL-2 in RSV-
infected patients, we found that the proliferative response of CD4+ T cell induced by 
PHA, assessed by detecting Ki-67 antigen expression, was substantially lower in RSV-
infected infants compared with HD. The addition of IL-2 significantly increased the 
proliferative response of CD4+ T cells, however, even in the presence of exogenous IL-
2, the proliferative response of CD4+ T cells from RSV-infected infants was markedly 
lower compared with HD (Fig. 1C). This suggests that factors other than IL-2 
production might also compromise the expansion of T cells in RSV-infected infants. 
Because the activation of STAT5 is one of the earliest events in IL-2 signaling through 
the high affinity IL-2 receptor [21], we analyzed STAT5 phosphorylation in response to 
IL-2 stimulation. We found a similar pattern of phosphorylation in CD4+ T cells from 
both RSV-infected infants and HD (Fig. 1D), suggesting that the IL-2-STAT5 pathway 
is preserved during infection.  
 
IL-2 increases the frequency of FOXP3+ Tregs in PBMCs from RSV-infected infants  
We have previously reported that severe RSV infection in infants is associated with a 
pronounced reduction in the frequency of circulating Tregs [9].  To explore whether 
exogenous IL-2 was able to restore the pool of Tregs, PBMCs were cultured with or 
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without IL-2 during 24 h, and the frequency of Tregs was then analyzed. IL-2 
significantly increased the frequency of FOXP3+CD4+ T cells in both HD and RSV-
infected infants. However, even after IL-2 treatment, the frequency of FOXP3+CD4+ T 
cells was shown to be significantly lower in RSV-infected infants compared with HD 
(Fig. 2A).  Reanalysis of the data by dividing patients according to their age into two 
groups (<6 months and >7 months), revealed that IL-2 failed to normalize the frequency 
of FOXP3+CD4+ T cells in both groups of patients (Fig. 2A, right panel). Moreover, 
as shown in Fig. 2B, IL-2-treatment also increased Treg expression of the 
ectonucleotidase CD39, which hydrolyzes ATP into the immunosuppressive agent 
adenosine [22]. This suggests that the increased expression of FOXP3 in CD4+ T cells 
from RSV-infected infants induced by IL-2 was actually associated with a regulatory 
signature. Interestingly, we found a negative correlation between CDSS values and the 
frequency of FOXP3+CD4+ T cells in IL-2-treated PBMCs, suggesting that a more 
severe disease is associated with a limited response to IL-2 (Fig. 2C). Further 
confirming the compromise in the compartment of FOXP3+CD4+ T cells in RSV-
infected infants, we found that the proliferative response of this cell subset in response 
to PHA stimulation, assessed either in the absence or presence of IL-2, was severely 
reduced (Fig. 2D).  
 
Soluble CD25 limit IL-2 function during severe RSV infection 
Elevated concentrations of sCD25 are found in autoimmunity, cancer and inflammatory 
conditions [20, 23]. Looking for factors that might affect the function of IL-2 in the 
course of RSV infection, we evaluated serum levels of sCD25 (IL-2 receptor α chain 
soluble form). It has been reported that serum from RSV-infected infants has increased 
amounts of sCD25 [24, 25]. In agreement with this observation, we found higher 
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amounts of sCD25 in the serum from RSV-infected infants compared with HD (Fig. 
3A). However, no correlation was found between disease severity and sCD25 levels 
(not shown). Because the ability of sCD25 to inhibit IL-2 activity remains controversial 
[20, 26, 27], we evaluated the effect of recombinant sCD25 on the function of IL-2 in 
CD4+T cells from RSV-infected infants. We found that both, IL-2 dependant STAT5 
phosphorylation and FOXP3 expression were significantly inhibited by the addition of 
recombinant sCD25 (Fig. 3B and C). Consistent with this observation, we found that 
serum from RSV-infected infants, but not from HD, diminished the frequency of 
FOXP3+CD4+ T cells in PBMCs isolated form healthy donors, cultured with or without 
IL-2 (Fig. 3D). Moreover, we found a significant positive correlation between the 
ability of serum from RSV-infected children to reduce the frequency of FOXP3+CD4+ 
T cells and their content in sCD25 (Fig. 3D, right panel). 
 
Activated conventional CD4+ T cells and Tregs are the main sources of sCD25 [20]. 
Since severe RSV infection is associated with a marked depletion of Tregs [9] we 
speculated that conventional CD4+ T cells might be the primary source of sCD25. In 
fact, we found that FOXP3- CD4+ T cells from RSV infected infants, express not only a 
higher frequency of CD25+ cells compared with HD, but also a great expression of 
CD25 measured as MFI (Fig. 4A). A very low or negligible percentage of CD25+ cells 
was detected in CD8+ T cells, B cells and monocytes (Fig. 4B). Interestingly, we 
observed an inverse correlation between the frequency of peripheral blood FOXP3+ 
Tregs and the levels of serum sCD25 when HD and RSV-infected infants were analyzed 
collectively (Fig. 4C), suggesting that sCD25 might actually act as a decoy receptor for 
IL-2 during severe RSV infection.  
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DISCUSSION  
 
Our results suggest that both, the production and function of IL-2 is compromised in the 
course of severe RSV infection in infants. We found that conventional CD4+ T cells 
from RSV infected infants produce low amounts of IL-2. Moreover, we observed that 
exogenous IL-2 was unable to fully restore IL-2 dependent functions such as the 
proliferative response of CD4+ T cells and the expansion of Tregs. These observations 
suggest that different mechanisms contribute to limit the function of IL-2 in the scenario 
of RSV disease. Interestingly, this phenomenon might contribute to explain not only the 
depletion of circulating Tregs, but also an essential feature of RSV infection; its 
inability to promote a robust memory T cell response [2, 3, 28, 29]. In this regard, it 
should be mentioned that IL-2 is required for the effective generation of effector and 
memory CD8+ T cells [30]. Moreover, it has been reported that the impaired effector 
and memory function of CD8+ T cells as well as the antibody response observed in 
RSV-infected animals were marke ly improved by administration of IL-2, being these 
effects associated to a reduced weight loss and illness in challenged mice [31].  
 
A reduced capacity of conventional CD4+ T cells to produce IL-2 has been previously 
described in either autoimmunity or infectious diseases. Autoimmune diseases such as 
type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus are associated to 
a defective ability of CD4+ T cells to secrete IL-2 [32-35]. This defect appears to 
explain the decrease of Tregs, favoring the expansion of autoreactive T cells [32]. On 
the other hand, observations made in experimental models of infections induced by 
T.gondi, L. monocytogenes and vaccinia virus, have shown that the acute infection 
phase is associated to a limited production of IL-2, resulting in a diminished Treg 
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frequency [36, 37]. Regarding RSV infection, previous studies suggested that the 
production of IL-2 by CD4+ T cells might be limited. Using PBMCs from adults who 
have been naturally and recurrently exposed to RSV and influenza A virus (IAV), 
Fleming and coworkers have reported that in vitro exposure to RSV results in a reduced 
production of IL-2 and a low lymphocyte proliferative response, compared to IAV-
stimulated cells, despite that PBMCs from adult donors expressed a similar frequency of 
specific T lymphocytes for both viruses [38]. Moreover, we have reported that activated 
CD4+ T cells are permissive to RSV infection, and also that infection promotes a 
marked inhibition of IL-2 production [39]. 
 
IL-2 availability during RSV infection might be limited, not only by a decreased 
production, but also by the high systemic levels of sCD25. Consistent with previous 
studies [24, 25], we found high amounts of sCD25 in the serum from RSV infected 
infants. Elevated serum concentrations of sCD25 have been reported in inflammatory 
conditions [20, 23]. Activated conventional T cells, Tregs and dendritic cells can release 
sCD25 by proteolytic cleavage of surface CD25 [20]. Our observations show a great 
expression of CD25 on conventional CD4+ T cells from RSV infected infants, 
suggesting that they might be the main source of sCD25. Regarding the biological 
significance of sCD25, it appears to compete with activated T cells for IL-2 binding, 
thereby reducing T cell proliferation [20, 26]. However, it has also been described that 
sCD25 might enhance the biological activity of IL-2. In fact, by forming a complex 
with IL-2, sCD25 has shown to enhance IL-2-mediated phosphorylation of STAT5 in 
CD4+ T cells, promoting their differentiation into inducible FOXP3+Tregs [27]. These 
observations suggest that sCD25 might either decrease or enhance the biological 
activity of IL-2, depending on the experimental setting. Our observations showing that 
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sCD25 partially inhibits the ability of IL-2 to induce both, STAT5 phosphorylation and 
FOXP3 expression in CD4+ T cells from RSV infected infants, suggest that sCD25 acts 
as a decoy receptor for IL-2 during severe RSV disease. 
 
We found that IL-2 significantly increased the proliferative response and the expression 
of FOXP3 in CD4+ T cells from RSV-infected infants. However, even in the presence 
of IL-2, both the proliferation rate of CD4+ T cells and the expression of FOXP3 
remained substantially lower in CD4+ T cells from RSV infected infants compared with 
HD. This suggests that factors other than IL-2 availability might compromise the 
activity of IL-2 during severe RSV infection. Contrasting with other acute viral 
infections such as those produced by measles virus and cytomegalovirus, RSV infection 
is not associated with a generalized immunologic hyporesponsiveness [2, 40]. On the 
other hand, our results showing that IL-2 induced a similar pattern of STAT5 
phosphorylation in CD4+ T cells from RSV infected infants and HD, suggest that 
signaling through the IL-2 receptor is preserved. Several factors might account for the 
limited activity of IL-2 in the course of RSV infection. Mediators such as IL-4, TGF-β, 
type I interferons and Prostaglandin E2 are produced at high levels in the context of 
RSV infection, being all of them capable of damping the function of IL-2 [41-46].   
 
All patients recruited in our study required hospitalization and supplemental oxygen. 
We analyzed the impact of disease severity on IL-2 production and IL-2 ability to 
restore the pool of FOXP3+CD4+ T cells. This analysis revealed a significant negative 
correlation for both parameters, suggesting that patients with a more severe disease 
produce lower levels of IL-2 and show a limited response to IL-2. It should be noted 
that although IL-2 failed to fully restore in vitro the function of CD4+ T cells from 
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiy180/4955865
by University of California-SB user
on 03 April 2018
Ac
ce
pte
d M
an
us
cri
pt
 
17 
 
RSV-infected infants, it significantly improved both, the proliferative response of CD4+ 
T cells and the frequency of FOXP3+CD4+ T cells. Interestingly, observations made in 
experimental models of RSV infection have shown that IL-2 administration improves 
disease outcome in RSV challenged mice [31]. Proof-of-concept clinical trials have 
shown that at low doses, IL-2 improves autoimmune and inflammatory conditions [32]. 
Further studies are needed to define whether IL-2 might represent a useful therapeutic 
tool in severe RSV infection.  
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Table 1. Baseline Characteristics of Children Infected with Respiratory  
Syncytial Virus  
                                                                      RSV patients      Healthy children 
       N = 85        N = 40 
Demographic characteristics     
Age, mo, mean ± SD 7.5 ± 7.1 12.6 ± 3.8 
Male sex, n (%) 57 (67%) 22 (55%) 
Disease severity 
  CDSS, n (%)* 
                                                               0-6 0 (0%) N/A 
                                                            7-8 48 (57%) N/A 
 9-12 37 (43%) N/A 
O2 req, n (%) 85 (100%) N/A 
Hospital stay, days, mean ± SD 7.3 ± 0.2 N/A 
PICU admision, n (%) 3 (3.6%) N/A 
Laboratory parameters 
  WBC, counts/mm
3
, mean ± SD 10,559 ± 4,021 8,952 ± 1,250 
Lymphocytes, %, mean ± SD   37.4 ± 15.4      53.1 ± 4.0 
CD4+, %, mean ± SD#    28.0 ± 11.0      32.3 ± 5.7 
CD8+, %, mean ± SD#  12.4 ± 6.8      20.0 ± 7.5 
CD19+, %, mean ± SD#     36.4 ± 10.2      16.5 ± 7.2 
Mo: months 
*CDSS was calculated using the modified-Tal score 
PICU: pediatric intensive care unit 
# Percentages of cell subsets in the gate of lymphocytes (n=12 in each group) 
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FIGURE LEGENDS   
 
Figure 1. CD4+ T cells from RSV-infected infants produce low amounts of IL-2 
and show a limited proliferative response. (A) PBMCs from HD (n=8) and RSV-
infected infants (n=20) were stimulated with PMA/Ionomycin in the presence of 
monensin for 5 h. Percentage of IL-2+CD4+ T cells and the MFI of IL-2 staining in the 
gate of IL-2+CD4+ T cells were analyzed by flow cytometry. The correlation between 
disease severity (CDSS) and the MFI of IL-2 staining is also shown (Spearman rank 
correlation test). Right panel shows the MFI of IL-2 staining in PBMCs from HD (n=8) 
and RSV-infected infants >7 months (n=6) and <6 months (n=13). (B) Levels of 
different cytokines in the supernatant of PHA-activated PBMCs after 3d of culture, 
quantified by a cytometric bead assay (CBA; n= 12 in each group). (C) PHA-activated 
PBMCs were cultured in the absence or presence of IL-2 (20 ng/ml) for 3 d (n=12 for 
each group). Frequency of Ki-67+CD4+ T cells in the gate of CD4+ T cells was then 
evaluated by flow cytometry. (D) PBMCs were treated, or not, with IL-2 (20 ng/ml) for 
30 min at 37°C (n=10 for each group). Frequency of pSTAT5+CD4+ T cells was then 
analyzed by flow cytometry. Representative experiments are shown in A (middle 
panel), C (right panel) and D (right panel). Mean ± SEM of n donors are shown in A, B, 
C and D. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. MFI (mean fluorescence 
intensity). 
 
Figure 2. IL-2 increases the frequency of FOXP3+CD4+ T cells in PBMCs from 
RSV-infected infants. (A) PBMCs from HD (n=8) and RSV-infected infants (n=41) 
were stimulated, or not, with IL-2 (20 ng/ml) for 24 h. Frequency of FOXP3+CD4+ T 
cells was analyzed by flow cytometry. Left panel shows the analysis of all patients 
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while the right panel shows the analysis of patients divided into two groups: >7 months 
(n=19) and <6 months (n=22). (B) Frequency of CD39+FOXP3+CD4+ T cells in 
PBMCs from RSV-infected children cultured for 24 in the absence or presence of IL-2 
(20 ng/ml, n=18). (C) Correlation between the frequency of FOXP3+CD4+ T cells in 
PBMCs from RSV-infected infants cultured for 24 with IL-2 (20 ng/ml) and CDSS 
values, analyzed by using the Spearman rank correlation test.  (D) PBMCs from HD and 
RSV-infected infants were activated with PHA (4 µg/ml) and cultured in the absence or 
presence of IL-2 (20 ng/ml) for 3 d (n=12 for each group). Frequency of Ki-
67+FOXP3+CD4+ T cells was evaluated by flow cytometry. Representative 
experiments are shown in A (middle panel) and B (right panel). Mean ± SEM of n 
donors are shown in A (left and right panel), B (left panel), and D. **p<0.01, 
***p<0.001 and ****p<0.0001.  
 
Figure 3. Soluble CD25 interferes with IL-2 function in RSV-infected children. (A) 
Levels of sCD25 in the serum from RSV-infected (n=24) and HD (n=21) were 
quantified by ELISA. (B-C) PBMCs from RSV-infected infants were cultured with IL-2 
(20 ng/ml) or IL-2 plus sCD25 (200 ng/ml) for 30 min (B) or 24 h (C). Then, the 
frequencies of pSTAT5+CD4+ T cells (n=12) or FOXP3+CD4+ T cells (n=7) were 
analyzed by flow cytometry (B and C, respectively). (D) PBMCs from healthy donors 
were incubated for 24 h with or without serum from healthy (n=9) or RSV-infected 
children (final dilution 1:10; n=9), in the absence or presence of IL-2 (20 ng/ml). Then, 
the frequency of FOXP3+CD4+ T cells was analyzed by flow cytometry (left and 
middle panel). Right panel shows the correlation between the ability of serum from 
RSV-infected infants to reduce the frequency of FOXP3+CD4+ T cells and serum 
levels of sCD25 (Spearman rank correlation test).  Fold decrease of FOXP3+CD4+ T 
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cell frequency was calculated as the ratio between the frequencies of FOXP3+CD4+ T 
cells cultured in the absence and presence of serum from RSV-infected children. 
Representative experiments are shown in B (right panel) and D (middle panel). Mean ± 
SEM of n donors are shown in A, B (left panel), C, and D (left panels).*p<0.05, 
**p<0.01 and ***p<0.001.  
 
Figure 4. High expression of CD25 in conventional CD4+ T cells from RSV-
infected infants. (A) Frequency and MFI of CD25 on gated FOXP3- CD4+ T cells 
from HD (n=9) and RSV-infected infants (n=21), evaluated by flow cytometry. (B) 
Percentage of CD25 on gated CD4+, CD8+, CD19+ and CD14+ cells from RSV-
infected infants (n= 15). (C) Correlation between the frequency of FOXP3+CD4+ T 
cells and the serum levels of sCD25 in the group of healthy and RSV-infected children 
analyzed together, by using the Spearman rank correlation coefficient test. 
Representative experiments are shown in A (right panel). Mean ± SEM of n donors are 
shown in A (left and middle panel) and B. **p<0.01 and ****p<0.0001.  
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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